Affinivax Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Affinivax Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10966
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Affinivax Inc (Affinivax) is a biotechnology company that develops vaccines for infectious diseases. The company uses Multiple Antigen Presenting System technology to enable affinity binding of protective polysaccharides and proteins in a single vaccine. It develops vaccine programs for streptococcus pneumoniae, and bacterial nosocomial infections. Affinivax provide pipeline of vaccines for both children and adults. The company significant advance vaccine technologies to induce protective immune responses. The company works in collaboration with various pharmaceutical companies for the development of vaccines. Affinivax is headquartered in Lexington, Massachusetts, the US.

Affinivax Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Affinivax Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Affinivax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Affinivax Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Affinivax Raises USD7 Million in Venture Financing 10
Affinivax Raises USD2.5 Million in Venture Financing 11
Affinivax Raises USD4 Million in Seed Venture Financing 12
Partnerships 13
Nosocomial Vaccine Enters into Agreement with Affinivax and University of Maryland 13
Affinivax Enters into Development Agreement with PATH for Pneumococcal Disease 14
Licensing Agreements 15
Astellas Pharma Enters into Licensing Agreement with Affinivax 15
Affinivax Enters into Licensing Agreement with Boston Children’s Hospital for MAPS Technology 16
Affinivax Inc – Key Competitors 17
Affinivax Inc – Key Employees 18
Affinivax Inc – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Affinivax Inc, Pharmaceuticals & Healthcare, Key Facts 2
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Affinivax Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Affinivax Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Affinivax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Affinivax Raises USD7 Million in Venture Financing 10
Affinivax Raises USD2.5 Million in Venture Financing 11
Affinivax Raises USD4 Million in Seed Venture Financing 12
Nosocomial Vaccine Enters into Agreement with Affinivax and University of Maryland 13
Affinivax Enters into Development Agreement with PATH for Pneumococcal Disease 14
Astellas Pharma Enters into Licensing Agreement with Affinivax 15
Affinivax Enters into Licensing Agreement with Boston Children’s Hospital for MAPS Technology 16
Affinivax Inc, Key Competitors 17
Affinivax Inc, Key Employees 18

List of Figures
Affinivax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Affinivax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Affinivax Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chiesi USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Chiesi USA Inc (Chiesi USA), a specialty pharmaceutical company, is a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. The company researches, develops, produces and commercializes innovative products in the areas such as cardiovascular, respiratory, neonatology, rare disease and specia …
  • MimiVax LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary MimiVax LLC (MimiVax) is a pharmaceutical company that discovers and develops immunotherapeutic vaccines and targeted therapies for the treatment of cancer. The company’s lead candidate is SurVaxM. Its SurVaxM is a cancer vaccine that stimulates a potent immune response and the survivin mole …
  • JP Elektroprivreda BiH d.d. Sarajevo (JPESR):企業の財務・戦略的SWOT分析
    JP Elektroprivreda BiH d.d. Sarajevo (JPESR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • CGN New Energy Holdings Co Ltd (1811):企業の財務・戦略的SWOT分析
    CGN New Energy Holdings Co Ltd (1811) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Mediaset S.p.A.:企業の戦略・SWOT・財務情報
    Mediaset S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Mediaset S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • UOB Private Banking:企業の戦略・SWOT・財務情報
    UOB Private Banking - Strategy, SWOT and Corporate Finance Report Summary UOB Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Glory Ltd
    Glory Ltd - Strategy, SWOT and Corporate Finance Report Summary Glory Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Wilton Resources Inc (WIL):石油・ガス:M&Aディール及び事業提携情報
    Summary Wilton Resources Inc (Wilton Resources) is an exploration and development company that develops oil and gas reserves. The company offers exploration of underdeveloped conventional and unconventional resources with prime focus on African continent. It operates in the process of acquiring oil …
  • IntelliCell BioSciences Inc:企業の戦略的SWOT分析
    IntelliCell BioSciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Enel Americas SA:企業の戦略・SWOT・財務分析
    Enel Americas SA - Strategy, SWOT and Corporate Finance Report Summary Enel Americas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Glanbia Nutritionals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Glanbia Nutritionals Inc (Glanbia Nutritionals) is a global provider of nutritional ingredients, functional ingredients, and customized premix solutions. The company manufactures and markets customized micronutrient blends, vitamins, minerals, amino acids, colors and specialty ingredients. T …
  • REVA Medical Inc (RVA):製品パイプライン分析
    Summary REVA Medical Inc (REVA) is a medical device company that develops minimally invasive medical devices. The company’s product includes bioresorbable polymers. Its bioresorbable polymers can be applied to a variety of medical applications. REVA’s fantom sirolimus-eluting bioresorbable scaffold …
  • Rich Pharmaceuticals Inc (RCHA)-製薬・医療分野:企業M&A・提携分析
    Summary Rich Pharmaceuticals Inc (Rich Pharmaceuticals) is a biopharmaceutical company that offers discovery and development of therapies for the treatment of cancer and neurological disorders. The company’s pipeline portfolio offers a lead drug candidate for the treatment of acute myeloid leukemia …
  • Harel Insurance Investments and Financial Services Ltd:企業の戦略・SWOT・財務情報
    Harel Insurance Investments and Financial Services Ltd - Strategy, SWOT and Corporate Finance Report Summary Harel Insurance Investments and Financial Services Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company' …
  • Mobile Telesystems:企業の戦略・SWOT・財務分析
    Mobile Telesystems - Strategy, SWOT and Corporate Finance Report Summary Mobile Telesystems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Union Jack Oil plc (UJO):石油・ガス:M&Aディール及び事業提携情報
    Summary Union Jack Oil plc (Union Jack Oil), formerly Union Jack Oil Ltd is an onshore oil and gas company that offers exploration and development of hydrocarbon projects. The company develops its portfolio of oil and gas assets by acquiring interests in drill ready prospects. It holds license inter …
  • Yuanta Financial Holding Co., Ltd.:企業の戦略・SWOT・財務情報
    Yuanta Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yuanta Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Societe Generale S.A.:戦略・SWOT・企業財務分析
    Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report Summary Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ampio Pharmaceuticals Inc (AMPE):企業の財務・戦略的SWOT分析
    Summary Ampio Pharmaceuticals Inc (Ampio) formerly Chay Enterprises Inc, operates as a bio pharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company develops compounds that decrease inflammation by inhibiting specific pro-inflammatory co …
  • Ocean Power Technologies Inc (OPTT):電力:M&Aディール及び事業提携情報
    Summary Ocean Power Technologies, Inc. (OPT) is a provider of ocean energy solutions. The company harnesses the abundant wave power to draw out renewable energy; and commercializes ocean wave power conversion technology products. The company's PB3 PowerBuoy integrates patented technologies in hydrod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆